Jiangsu
China
3
2023-05-25
3
2025-12-02
These are the the leading inventors for applications assigned to Pharmablock Sciences (Nanjing), Inc.:
Pharmablock Sciences (Nanjing), Inc. based in Jiangsu, CN has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
CBP/EP300 INHIBITOR AND USE THEREOF
#2 | 2022-09-08 ✅ Patent 12,479,846 granted on 2025-11-25EZH2 INHIBITOR AND USE THEREOF
#3 | 2020-12-24 ✅ Patent 11,591,326 granted on 2023-02-28Inhibitors of protein arginine methyltransferase 5 (PRMT5), pharmaceutical products thereof, and methods thereof
Also check out PHARMABLOCK SCIENCES (NANJING), INC.'s (Jiangsu, China) applicant profile with 2 patent applications submitted.
358751 ⎘